↓ Skip to main content

Dove Medical Press

Article Metrics

Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#43 of 2,663)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
7 news outlets
twitter
20 tweeters
patent
3 patents
facebook
6 Facebook pages
wikipedia
1 Wikipedia page
googleplus
1 Google+ user
reddit
1 Redditor
video
1 video uploader

Citations

dimensions_citation
87 Dimensions

Readers on

mendeley
167 Mendeley
Title
Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy
Published in
Neuropsychiatric Disease and Treatment, August 2015
DOI 10.2147/ndt.s65809
Pubmed ID
Authors

Theodore A. Henderson, Larry Morries, Paolo Cassano

Abstract

Traumatic brain injury (TBI) is a growing health concern affecting civilians and military personnel. In this review, treatments for the chronic TBI patient are discussed, including pharmaceuticals, nutraceuticals, cognitive therapy, and hyperbaric oxygen therapy. All available literature suggests a marginal benefit with prolonged treatment courses. An emerging modality of treatment is near-infrared (NIR) light, which has benefit in animal models of stroke, spinal cord injury, optic nerve injury, and TBI, and in human trials for stroke and TBI. The extant literature is confounded by variable degrees of efficacy and a bewildering array of treatment parameters. Some data indicate that diodes emitting low-level NIR energy often have failed to demonstrate therapeutic efficacy, perhaps due to failing to deliver sufficient radiant energy to the necessary depth. As part of this review, we present a retrospective case series using high-power NIR laser phototherapy with a Class IV laser to treat TBI. We demonstrate greater clinical efficacy with higher fluence, in contrast to the bimodal model of efficacy previously proposed. In ten patients with chronic TBI (average time since injury 9.3 years) given ten treatments over the course of 2 months using a high-power NIR laser (13.2 W/0.89 cm(2) at 810 nm or 9 W/0.89 cm(2) at 810 nm and 980 nm), symptoms of headache, sleep disturbance, cognition, mood dysregulation, anxiety, and irritability improved. Symptoms were monitored by depression scales and a novel patient diary system specifically designed for this study. NIR light in the power range of 10-15 W at 810 nm and 980 nm can safely and effectively treat chronic symptoms of TBI. The clinical benefit and effects of infrared phototherapy on mitochondrial function and secondary molecular events are discussed in the context of adequate radiant energy penetration.

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 167 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Unknown 166 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 17%
Student > Bachelor 25 15%
Other 17 10%
Student > Master 16 10%
Student > Ph. D. Student 16 10%
Other 42 25%
Unknown 22 13%
Readers by discipline Count As %
Medicine and Dentistry 42 25%
Psychology 27 16%
Neuroscience 21 13%
Agricultural and Biological Sciences 10 6%
Nursing and Health Professions 8 5%
Other 29 17%
Unknown 30 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 62. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2021.
All research outputs
#409,549
of 17,355,315 outputs
Outputs from Neuropsychiatric Disease and Treatment
#43
of 2,663 outputs
Outputs of similar age
#7,164
of 244,344 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#4
of 108 outputs
Altmetric has tracked 17,355,315 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,663 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 244,344 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.